Cureline Baltic COO Agne Vaitkeviciene has presented Cureline Group - Global Translational CRO activies in preclinical and translational research at Bioplus Interphaex Korea 2022. Cureline Human Biospecimen CRO
Facebook Twitter LinkedIn
  • Home
  • Team
  • Partners
  • R&D Projects
  • News
  • Contact
  • Home
  • Team
  • Partners
  • R&D Projects
  • News
  • Contact

Cureline Baltic COO Agne Vaitkeviciene has presented Cureline Group - Global Translational CRO activies in preclinical and translational research at Bioplus Interphaex Korea 2022.

Cureline Baltic COO Agne Vaitkeviciene has presented Cureline Group - Global Translational CRO activies in preclinical and translational research at Bioplus Interphaex Korea 2022.

Thank you Lithuanian Biotechnology Association Innovation Agency Lithuania and Embassy of Lithuania to S. Korea team for organizing opportunity to visit Seoul and meet our potential partners and clients.

  • 1659592746274
  • 1659592747673
  • 1659592748635
  • 1659592757251
  • 1659592757892
  • 1659592761749

We’re here to help

Talk to one of our team members and find out more.

Contact us
Cureline Baltic COO Agne Vaitkeviciene has presented Cureline Group - Global Translational CRO activies in preclinical and translational research at Bioplus Interphaex Korea 2022.

A global translational and precision medicine CRO providing HBS biobanking and laboratory services for accelerated drug R&D and Dx development

  • Cureline, Inc 
    Global commercial HBS biobank
  • Cureline Biopathology,
    Precision histopathology laboratory
  • Cureline Molecular 
    Analytical services laboratory
  • BioCrypton, Inc 
    Glycoproteomics and biomarkers
  • HBS Biorepository 
    in San Francisco, CA (USA)

San Francisco, USA

Cureline Group HQ:

Cureline, Inc.

150 N. Hill Dr., Ste 24, Brisbane, CA 94005

USA. 

Vilnius, Lithuania

Cureline Baltic HQ: 

Innovative Medicine Center

Santariškių g. 5, LT-08406,

Vilnius, Lithuania

 

Facebook Twitter LinkedIn
  • Home
  • Team
  • Partners
  • R&D Projects
  • News
  • Contact